Moreover, the CAT activity was decreased by 33% in the vehicle-treated colitis group compared with the naive (noncolitis) group, and the treatment with HEBD (300 mg/kg) increased by 41% the activity of this enzyme compared with the vehicle group (Table 2). The gene discussed is CAT; the disease is colitis.